Skip to search formSkip to main contentSkip to account menu

gp100 Human Melanoma Peptide Vaccine with Incomplete Freund's Adjuvant

Known as: gp100 human melanoma peptide vaccine/incomplete Freund's adjuvant, gp100 human melanoma-associated antigen with incomplete Freund's adjuvant, gp100 human melanoma-associated antigen/incomplete Freund's adjuvant 
A vaccine consisting of synthetic glycoprotein 100 (gp100) melanoma antigen and incomplete Freund's adjuvant (IFA), an emulsifying agent and immune… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Cell Recruitment and Cytokines in Skin Mice Sensitized with the Vaccine Adjuvants: Saponin, Incomplete Freund’s Adjuvant, and Monophosphoryl Lipid A
Vaccine adjuvants are substances associated with antigens that are fundamental to the formation of an intense, durable, and fast… 
Highly Cited
2010
Highly Cited
2010
Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen.
2006
2006
Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.
In this work, we assessed the efficacy of an experimental intranasal vaccine against urinary-tract infections. The vaccine… 
Highly Cited
2003
Highly Cited
2003
The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.
A number of studies in animal models and humans have shown that both humoral andcell-mediated immune responses play an important… 
Highly Cited
2001
Highly Cited
2001
Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in anAotus Challenge Trial
ABSTRACT In an attempt to produce a more defined, clinical-grade version of a vaccine based on Plasmodium falciparum merozoite… 
Highly Cited
1998
Highly Cited
1998
New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH.
Highly Cited
1994
Highly Cited
1994
Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells.
A 1-year study measured the effect of administration of an inactivated human immunodeficiency virus type 1 (HIV-1) immunogen in… 
Highly Cited
1990
Highly Cited
1990
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
Rhesus macaques (Macaca mulatta) immunized with an inactivated whole SIVmac vaccine and muramyl dipeptide (MDP), incomplete… 
Highly Cited
1989
Highly Cited
1989
Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.
A prospective cohort study was undertaken in two commercial California dairies. The treatment group, 246 cows, received three… 
Highly Cited
1987
Highly Cited
1987
Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.
The gangliosides GM2, GD2, and GD3 are differentiation antigens largely restricted to cells of neuroectodermal origin. They are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)